Organic sales and core EPS grew within guidance in FY26 despite cost headwinds, with broad-based category and regional growth. FY27 guidance anticipates 1%-3% organic sales growth and continued strong shareholder returns, while interventions and innovation aim to accelerate share and category growth.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.